To learn more, please call our Research Department at (513) 751-2273 or email
mhoelle@ohcare.com
| metastatic |
| Study number: |
GU 75 Eli Lilly I2V-MC-CXAB |
| Protocol title: |
Randomized, Multicenter, Open-label, Active Controlled, Phase 2 Study of LY2510924 and Sunitinib versus Sunitinib in Patients with Metastatic Renal Cell Carcinoma |
| Status |
Open
|